QC Senior Microbiologist - Oxford, Oxfordshire, United Kingdom - Oxford BioMedica (UK) Limited

Description

We are currently recruiting for a QC Microbiologist to join the Quality Control team on a 12 monthfixed term contract to cover a maternity period.

The purpose of this role is to test and report on raw materials, intermediates, finished products, the manufacturing environment and stability samples to enable product release and meet regulatory requirements.

Test and report on raw materials, intermediates, finished products and the manufacturing environment to enable product release to meet regulatory requirements.

Support internal audits to maintain and improve Quality systems.
Maintain stock control of QC test materials for use within the Microbiology Lab and Production areas.
Co-ordinate microbiology OOS/OOT results to help identify contributory factors and assign root cause.
Support Senior Microbiologist and QC Manager with training of new staff.
HND/Degree level qualified in Microbiology or related subject
Relevant experience in Microbiology laboratory techniques
Computer literate (Word, Excel), Good familiarity with Microsoft Office software
Flexibility to work shifts covering the hours from 07.00 Mon-Fri

Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors;

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.

These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
Highly competitive total reward packages
Wellbeing programmes
Development opportunities
State of the art laboratory and manufacturing facilities

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells.

One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells.

This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.

These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
#